ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Autoantibody(ies)"

  • Abstract Number: 1064 • ACR Convergence 2020

    Anti-SMN Autoantibodies Are Associated with Systemic Sclerosis Small Bowel Involvement in anti-U1RNP Positive Autoimmune Myositis

    Caroline Vo1, Océane Landon-Cardinal2, Alexandra Albert3, Alain Meyer4, Valérie Leclair5, Josiane Bourré-Tessier2, Sabrina Hoa2, Eric Rich1, Jean-Richard Goulet1, Benjamin Ellezam6, Maude Bouchard-Marmen7, Martial Koenig8, Geneviève Gyger5, Ira N. Targoff9, Marie Hudson5, Minoru Satoh10, Marvin Fritzler11, Yves Troyanov12 and Jean-Luc Senécal2, 1Division of Rheumatology, Centre hospitalier de l'Université de Montréal, Department of Medicine, Université de Montréal, Montréal, QC, Canada, 2Division of Rheumatology, Centre hospitalier de l'Université de Montréal, Montréal, QC, Canada, 3Division of Rheumatology, Centre Hospitalier de l’Université Laval, Québec, QC, Canada, 4Service de rhumatologie et Centre de références des maladies autoimmunes rares, Hôpitaux universitaires de Strasbourg, Strasbourg, Alsace, France, 5Division of Rheumatology, Jewish General Hospital, Montréal, QC, Canada, 6Division of Pathology, Centre hospitalier universitaire Sainte-Justine, Montréal, QC, Canada, 7Division of Rheumatology, Centre Hospitalier de l’Université Laval, Department of Medicine, Université Laval, Québec, QC, Canada, 8Division of Internal Medicine, Centre hospitalier de l'Université de Montréal, Department of Medicine, Université de Montréal, Montréal, QC, Canada, 9University of Oklahoma Health Sciences Center, Oklahoma City, OK, 10Department of Clinical Nursing, University of Occupational and Environmental Health, Kitakyushu, Japan, 11Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 12Division of Rheumatology, Hôpital du Sacré-Coeur, Montréal, QC, Canada

    Background/Purpose: The survival of motor neuron (SMN)/gemin proteins are components of a multifunctional protein complex that plays an essential role in RNA metabolism. SMN is…
  • Abstract Number: 1415 • ACR Convergence 2020

    Murine Roseolovirus Induces Autoimmune Disease and Development of Autoreactive T Cells and Autoantibodies

    Tarin Bigley1, Jose Saenz2, Li-Ping Yang2, Jason Mills2 and Wayne Yokoyama2, 1Washington University in St. Louis, Saint Louis, MO, 2Washington University in St. Louis, St. Louis, MO

    Background/Purpose: Murine roseolovirus (MRV) is a recently sequenced beta-herpesvirus that is a natural murine pathogen and is genetically highly related to HHV6 and HHV7. The…
  • Abstract Number: 1818 • ACR Convergence 2020

    IgG and IgA Autoantibodies Against L1 ORF1p Expressed in Granulocytes Correlate with Granulocyte Consumption and Disease Activity in Pediatric Systemic Lupus Erythematosus

    Kennedy Ukadike1, Kathryn Ni1, Victoria Carter1, Martin Taylor2, John LaCava3, Lauren Pachman4, Xiaoxing Wang1, Mary Eckert5, Anne Stevens1, Christian Lood1 and Tomas Mustelin1, 1University of Washington, Seattle, WA, 2Massachusetts General Hospital, Boston, MA, 3Rockefeller University, New York, NY, 4Department of Pediatrics, Northwestern University Feinberg School of Medicine; The Ann and Robert H. Lurie Children's Hospital of Chicago, Division of Pediatric Rheumatology; The CureJM Center of Excellence in Juvenile Myositis Research and Care, The Stanley Manne Children's Research Center of Chicago, Lake Forest, IL, 5Seattle Children's Hospital, Seattle, WA

    Background/Purpose: To quantitate autoantibodies against the RNA-binding p40 (ORF1p) protein encoded by the L1 retroelement, expression of p40 itself, and markers of neutrophil death in…
  • Abstract Number: 0761 • ACR Convergence 2020

    Anti-Peptidylarginine Deaminase Antibodies in the Individuals with Arthralgia at Risk of Progression to Rheumatoid Arthritis

    Nora Petrovská1, Klára Prajzlerová1, Ivana Půtová2, Monika Gregová1, Petra Hánová2, Heřman Mann3, Karel Pavelka1, Jiří Vencovský1, Ladislav Šenolt1 and Mária Filková1, 1Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic, 2Institute of Rheumatology, Prague, Czech Republic, 3Institute of Rheumatology, Prague, Czech Republic. Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, Prague, Czech Republic

    Background/Purpose: In order to identify the individuals at risk of imminent progression to rheumatoid arthritis (RA), EULAR has established a definition of clinically suspect arthralgia…
  • Abstract Number: 1068 • ACR Convergence 2020

    Efficacy of Early Initiation of Plasma Exchange Therapy for a Patient with Anti-MDA5 Autoantibody-Positive Dermatomyositis Developing Refractory Rapidly Progressive Interstitial Lung Disease

    Noriko Sasaki1, Akira Ishii1, Keigo Shimura1, Azusa Kojima1, Mai Sugiyama2, Yuto Izumi1, Kazuki Hirano1, Sho Sasaki2, Takayoshi Kurabayashi1, Yuji Hosono2, Chiho Yamada2 and Shinji Sato2, 1Tokai University School of Medicine, Isehara, Kanagawa, Japan, 2Tokai University School of Medicine, Isehara, Japan

    Background/Purpose: Dermatomyositis (DM), and particularly the subtype clinically amyopathic DM (CADM), is often associated with fatal rapidly progressive interstitial lung disease (RP-ILD) when anti-melanoma differentiation-associated…
  • Abstract Number: 1445 • ACR Convergence 2020

    Citrulline Reactive B Cells Are Present in the Lungs of Risk RA and Early Untreated RA

    Vijay Joshua1, Malena Loberg-Haarhaus2, Akilan Krishnamurthy1, Meng Sun3, Christina Gerstner4, Aase Hensvold5, Khaled Amara1, Lena Israelsson1, Ragnhild Stålesen6, Bence Rethi7, Magnus Sköld7, Johan Grunewald1, Heidi Wähämaa1, Caroline Grönwall1, Vivianne Malmström8 and Anca Catrina5, 1Karolinska Institutet, Stockholm, Sweden, 2Rheumatology clinic, Karolinska University Hospital, Stockholm, Sweden, Stockholm, Stockholms Lan, Sweden, 3Karolinska University Hospital and Karolinska Insitutet, Stockholm, Sweden, 4Division of Rheumatology, Department of Medicine,Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden, 5Rheumatology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden, Stockholm, Stockholms Lan, Sweden, 6Karolinska Institute, Stockholm, Sweden, 7Karolinska Institutet, Stockholm, 8Karolinska Institutet, Stockholm, Stockholms Lan, Sweden

    Background/Purpose: Structural changes, increased tissue citrullination, signs of local inflammation and anti-citrullinated protein autoantibodies (ACPA) are present in the pulmonary compartment of early untreated seropositive…
  • Abstract Number: 1830 • ACR Convergence 2020

    Adverse Drug Reactions to Trimethoprim-sulfamethoxazole as a Prophylactic Agent Against Pneumocystis Pneumonia in Patients with Systemic Lupus Erythematosus: anti-Sm Antibody as a Possible Risk Factor

    Shinji Izuka1, Hiroyuki Yamashita2, Yuko Takahashi2 and Hiroshi Kaneko2, 1Devision of Rheumatic Disease, National Center for Global Health and Medicine, Toshima-Ku, Tokyo, Japan, 2Devision of Rheumatic Disease, National Center for Global Health and Medicine, Shinjuku, Tokyo, Japan

    Background/Purpose: Pneumocystis pneumonia (PCP) is a life-threatening infection in immunocompromised patients, including those with connective tissue diseases (CTDs), treated with corticosteroids or immunosuppressive agents. Trimethoprim-sulfamethoxazole…
  • Abstract Number: 0767 • ACR Convergence 2020

    Anti-acetylated Protein Antibodies in Rheumatoid Arthritis (RA): Clues for the Starting Point of Autoantibody Responses in RA

    Tineke van Wesemael1, Nazike Salioska2, Annemarie Dorjée1, Thomas Huizinga1, Annette van der Helm - van Mil3, René Toes1 and Diane van der Woude1, 1Leiden university medical center, Leiden, Netherlands, 2leiden university medical center, Rotterdam, Netherlands, 3Leiden University Medical Center, Erasmus Medical Center, Leiden, Netherlands

    Background/Purpose: Rheumatoid arthritis (RA) is characterized by autoantibodies such as rheumatoid factor (RF) and anti-modified protein autoantibodies (AMPAs) like anti-citrullinated protein antibodies (ACPA) and anti-carbamylated…
  • Abstract Number: 1073 • ACR Convergence 2020

    Anti Melanoma Differentiation-associated Protein Gene 5 Antibody Titer Monitoring Is a Useful Indicator for Early Detection of Recurrence in Rapidly Progressive Interstitial Lung Disease Associated with Dermatomyositis

    Yuji Hosono1, Azusa Kojima2, Keigo Shimura2, Akira Ishii2, Yuto Izumi2, Kazuki Hirano2, Sho Sasaki2, Takayoshi Kurabayashi2, Noriko Sasaki2, Chiho Yamada2 and Shinji Sato2, 1Tokai University School of Medicine, Kanagawa, Japan, 2Tokai University School of Medicine, Isehara, Kanagawa, Japan

    Background/Purpose: Anti melanoma differentiation-associated gene 5 (MDA5) antibody (Ab) positive dermatomyositis (DM) often complicates rapidly progressive interstitial lung disease (RP-ILD), which shows fatal prognosis at…
  • Abstract Number: 1447 • ACR Convergence 2020

    Vitamin D Deficiency Enhances Antiphospholipid Antibody-Mediated Thrombosis in a Passive Immunization Mouse Model

    Rohan Willis1, Karen Roye-Green2, Zurina Romay-Penabad1, Elizabeth Papalardo1, Alvaro Schleh3, Vijaya Murthy4, Monica Smikle2 and Emilio Gonzalez1, 1University of Texas Medical Branch, Galveston, TX, 2University of the West Indies, Kingston, Jamaica, 3Antiphospholipid Standardization Laboratory, GALVESTON, TX, 4University of Texas Medical Branch, League City, TX

    Background/Purpose: Abnormal vitamin D levels occur frequently in antiphospholipid (APS) patients and are correlated with thrombosis. It remains unclear however if vitamin D deficiency observed…
  • Abstract Number: 1848 • ACR Convergence 2020

    Identification of Native and Citrullinated Autoantibodies to Psoriasis Related-antigen PsoP27 in Synovial Fluids of Patients with Psoriatic Arthritis

    Marina Slobodkin1, Smadar Gertel1, Ari Polachek2, Victoria Furer3 and Ori Elkayam4, 1Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel, 2Tel Aviv Sourasky Medical Center, Petah-Tikva, Israel, 3Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 4Tel Aviv Sourasky Medical Center,, Tel aviv, Israel

    Background/Purpose: Psoriatic arthritis (PsA) is an inflammatory joint disease with no serological biomarkers, hence diagnosis is based on clinical evaluation alone. PsA is closely associated…
  • Abstract Number: 0769 • ACR Convergence 2020

    Does the Autoantibody-Response Mature Between Presentation with Arthralgia and Development of Rheumatoid Arthritis? – a Longitudinal Serological Study

    Fenne Wouters1, Ellis Niemantsverdriet1, Nazike Salioska1, Annemarie Dorjée1, René Toes1 and Annette van der Helm - van Mil2, 1Leiden University Medical Center, Leiden, Netherlands, 2Leiden University Medical Center, Erasmus Medical Center, Leiden, Netherlands

    Background/Purpose: Auto-antibodies in rheumatoid arthritis (RA) are often present years before disease onset but their mere presence does not seem enough to induce RA. Several…
  • Abstract Number: 1075 • ACR Convergence 2020

    Diagnostic Utility of Myositis Antibodies in HyperCKemia: A University Affiliated Single Center Retrospective Study

    Sandeepkumar Gupta1, Debendra Pattanaik2, Tulio Bertorini2 and Amado Afreire3, 1Medical College Of Georgia at Augusta University Medical Center, Augusta, GA, 2University of Tennessee Health Science Center, Memphis, TN, 3University of Tennessee Health Science Cente, Memphis, TN

    Background/Purpose: Myositis specific and associated autoantibodies are now being used more frequently in the diagnosis of idiopathic inflammatory myositis. However there is a no study…
  • Abstract Number: 1456 • ACR Convergence 2020

    Exploring the RA Bone Marrow Niche by Single-cell Technology to Identify Long Lived ACPA+ Plasma Cells

    Khaled Amara1, Aase Hensvold2, Radha Thyagarajan1, Lena Israelsson1, Johanna Steen1, Heidi Wähämaa1, Monika Hansson1, Marianne Engström1, Annika van Vollenhoven1, Anca Catrina2, Vivianne Malmström3 and Caroline Grönwall1, 1Karolinska Institutet, Stockholm, Sweden, 2Rheumatology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden, Stockholm, Stockholms Lan, Sweden, 3Karolinska Institutet, Stockholm, Stockholms Lan, Sweden

    Background/Purpose: Autoantibodies is a hallmark of rheumatoid arthritis, placing the adaptive immune system and B-cells centrally in the pathogenesis. The anti-citrullinated autoantibodies (ACPA) detected in…
  • Abstract Number: 1910 • ACR Convergence 2020

    Integrated Molecular Analysis of Systemic Sclerosis Skin and Blood Highlights Significant Differences Between Major Autoantibody Subgroups

    Kristina Clark1, Corrado Campochiaro2, Eszter Csomor3, Adam Taylor3, Katherine Nevin3, Nicholas Galwey3, Mary Morse3, Voon Ong4, Emma Derrett-Smith5, Shaun Flint3 and Christopher Denton1, 1University College London, London, United Kingdom, 2Royal Free Hospital NHS trust, London, United Kingdom, 3GlaxoSmithKline, Stevenage, United Kingdom, 4UCL, London, United Kingdom, 5University College London Division of Medicine, London, United Kingdom

    Background/Purpose: The major antinuclear autoantibodies of systemic sclerosis (SSc) associate with different skin score trajectories and risk of internal organ manifestations.  To elucidate molecular differences…
  • « Previous Page
  • 1
  • …
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology